BDBM638402 Preparation of N-((1r,4r)-4-(3-Chloro-4-cyanophenoxy)cyclohexyl)-6-(4-(4-(((S)-4-ethyl-4,9-dihydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-10-yl)methyl)piperazine-1-carbonyl)piperidin-1-yl)pyridazine-3-carboxamide ::US11834458, Example 14

SMILES CC[C@@]1(O)C(=O)OCc2c1cc1-c3nc4ccc(O)c(CN5CCN(CC5)C(=O)C5CCN(CC5)c5ccc(nn5)C(=O)N[C@H]5CC[C@@H](CC5)Oc5ccc(C#N)c(Cl)c5)c4cc3Cn1c2=O

InChI Key InChIKey=GCDZGTMPUOMKIJ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 638402   

TargetAndrogen receptor(Human)
Nuvation Bio

US Patent
LigandPNGBDBM638402(US11834458, Example 14 | Preparation of N-((1r,4r)...)
Affinity DataIC50: 255nMAssay Description:To assess AR binding, test compound (top dose 10 μM, 4 fold serial dilution, 8 point dose response) and control (progesterone) were transferred ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/23/2024
Entry Details
Go to US Patent